Images Related To:
ESMO Congress 2012: MOLMED presented Update on NGR-hTNF
MolMed S.p.A. (MLM.MI) presented, at the 37th ESMO Congress, three studies on its investigational biological drug NGR-hTNF, including updated results in non-small cell lung cancer...